Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same
US-12552737-B2 · Feb 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Moaddel Ruin patents
Moaddel Ruin is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Moaddel Ruin |
| Total patents | 18 |
| First publication | Feb 23, 2017 |
| Latest publication | Feb 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US-12473251-B2 · Nov 18, 2025 · US
Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic pain
US-2025319092-A1 · Oct 16, 2025 · US
Gingerenone A prodrugs as sensotherapeutics and methods of use
US-12325688-B2 · Jun 10, 2025 · US
Gingerenone a prodrugs as sensotherapeutics and methods of use
US-2025115543-A1 · Apr 10, 2025 · US
Gingerenone a prodrugs and methods of use
US-2024374550-A1 · Nov 14, 2024 · US
Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine
US-2023192594-A1 · Jun 22, 2023 · US
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US-11613514-B2 · Mar 28, 2023 · US
Salts of (2r, 6r)-hydroxynorketamine, their crystal forms, and methods of making the same
US-2023022767-A1 · Jan 26, 2023 · US
Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine
US-2021139411-A1 · May 13, 2021 · US
Recent patents
Latest publications not already listed above.
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US-10919842-B2 · Feb 16, 2021 · US
Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic pain
US-2020360393-A1 · Nov 19, 2020 · US
Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine
US-2019135732-A1 · May 9, 2019 · US
Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disorders
US-2019083420-A1 · Mar 21, 2019 · US
Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
US-2018098993-A1 · Apr 12, 2018 · US
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
US-9867830-B2 · Jan 16, 2018 · US
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
US-9650352-B2 · May 16, 2017 · US
Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
US-2017049780-A1 · Feb 23, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Us Health | 15 |
| Cooper Health System | 6 |
| Stanford Res Inst Int | 6 |
| Univ Maryland | 6 |
| The Us Secretary Department Of Health And Human Servic | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07C225/20 | 14 |
| C07C2601/14 | 14 |
| C07B2200/07 | 14 |
| C07C2601/16 | 12 |
| A61P25/28 | 9 |